
Loading, please wait...

Loading, please wait...

Maharashtra and the rest of India saw a significant improvement in HIV treatment adherence during the 2025-26 period. Consequently, recent RTI data from the National AIDS Control Organisation (NACO) reveals a 57% drop in patients missing treatment. This progress brings India closer to the WHO goal of ending the AIDS epidemic by 2030.
In Maharashtra, however, only 611 people living with HIV (PLHIV) missed their follow-ups in 2025-26. This represents a sharp contrast to the 1,450 cases the city recorded in the previous year. Similarly, national figures fell from 20,312 to 9,200 during the same period. Therefore, health officials credit strengthened counseling and age-specific workshops for this significant success.
Furthermore, NACO defines "lost to follow-up" as a patient missing clinic visits for three to six months. Because this gap poses severe risks like drug-resistant strains, experts urge consistent patient monitoring. Moreover, activists fear many PLHIV still lack access to free antiretroviral treatment programs. Nonetheless, authorities continue to refine data as reports trickle in from various regional centers.
Q1: What defines a "lost to follow-up" case in HIV treatment?
NACO defines a patient as "lost to follow-up" if they miss clinic visits or fail to collect free medicines for a period between three and six months.
Q2: How much did the dropout rate decrease in Maharashtra?
The state recorded a 57% decrease, with the number of dropouts falling from 1,450 in 2024-25 to 611 in 2025-26.
Q3: What interventions are being used to prevent treatment dropouts?
Health officials have implemented strengthened counseling, role-playing workshops, and age-specific interventions for adolescents and senior citizens to ensure patient retention.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Maharashtra sees a 57% drop in HIV treatment dropouts in 2025-26. Learn how NACO interventions and counseling are improving patient adherence across India....
5 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today